Liom Non-invasive Continuous Glucose Monitor "Clinical Demo" (niCGM)
Recruiting · NCT06272136 · Interventional (participants receive a specific treatment) · Lead sponsor: Liom Health AG
View the official record on ClinicalTrials.gov →Interventions studied
Clinical Demo 2.0
What this trial is about
This is a single-centre, multiple cohort, open study.
Who can take part
Age range
18 Years to 65 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Male or female trial participant with clinically diagnosed type 1 or type 2 diabetes for at least 1 year.
- Age between 18 and 65 years, both inclusive.
- Treated with insulin and/or oral antidiabetic drugs (OADs; type 2 only), multiple dosing insulin therapy (MDI), continuous subcutaneous insulin infusion (CSII) or a hybrid closed loop system.
Exclusion criteria
- Known or suspected hypersensitivity to any of the components of the Liom Clinical Demo 2.0.
- Trial participant with any injury, infection, atypical skin condition (e.g., hyperkeratosis, hyperpigmentation) of or tattoo on the wrists.
- Presence or history of a cardiovascular disease including stable and unstable angina pectoris, myocardial infarction, transient ischaemic attack, stroke, cardiac decompensation, clinically significant arrhythmias or clinically significant conduction disorders.
Where it is running
1 location listed.
- Profil for Stoffwechselforschung GmbH - Neuss, Nordrhein-Westfallen, Germany